DK0983510T3 - Genkendelse af tumorspecifikke genprodukter i cancer - Google Patents

Genkendelse af tumorspecifikke genprodukter i cancer

Info

Publication number
DK0983510T3
DK0983510T3 DK98924666T DK98924666T DK0983510T3 DK 0983510 T3 DK0983510 T3 DK 0983510T3 DK 98924666 T DK98924666 T DK 98924666T DK 98924666 T DK98924666 T DK 98924666T DK 0983510 T3 DK0983510 T3 DK 0983510T3
Authority
DK
Denmark
Prior art keywords
tumor
specific gene
gene products
cancer
detection
Prior art date
Application number
DK98924666T
Other languages
Danish (da)
English (en)
Inventor
Paulus Benjamin Berendes
Janine Nicole Veenman
Denderen Adriana Cornelia Van
Ewijk Willem Van
Original Assignee
Univ Erasmus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Erasmus filed Critical Univ Erasmus
Application granted granted Critical
Publication of DK0983510T3 publication Critical patent/DK0983510T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57426Specifically defined cancers leukemia
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57496Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/82Translation products from oncogenes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK98924666T 1997-05-20 1998-05-20 Genkendelse af tumorspecifikke genprodukter i cancer DK0983510T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97201507 1997-05-20
PCT/NL1998/000289 WO1998053317A1 (en) 1997-05-20 1998-05-20 Recognition of tumour-specific gene products in cancer

Publications (1)

Publication Number Publication Date
DK0983510T3 true DK0983510T3 (da) 2004-07-05

Family

ID=8228328

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98924666T DK0983510T3 (da) 1997-05-20 1998-05-20 Genkendelse af tumorspecifikke genprodukter i cancer

Country Status (10)

Country Link
US (1) US6610498B1 (de)
EP (1) EP0983510B1 (de)
AT (1) ATE261125T1 (de)
AU (1) AU7677198A (de)
CA (1) CA2290656C (de)
DE (1) DE69822149T2 (de)
DK (1) DK0983510T3 (de)
ES (1) ES2217558T3 (de)
PT (1) PT983510E (de)
WO (1) WO1998053317A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6686165B2 (en) * 1997-05-20 2004-02-03 Erasmus Universiteit Rotterdam Recognition of tumor-specific gene products in cancer
AU2002220521A1 (en) * 2000-11-29 2002-06-11 Statens Seruminstitut A screening assay for detecting chromosome rearrangements or recombinations
DK1565746T3 (da) 2002-11-07 2011-01-10 Univ Erasmus Fremgangsmåde og prober til detektion af et tumor-specifikt fusionsprotein
EP1507147A1 (de) * 2003-08-12 2005-02-16 Erasmus University Medical Center Rotterdam Verfahren zum Nachweiss von niedrigem Gehalt an Fusionsprotein
US7242330B2 (en) * 2003-12-17 2007-07-10 Texas Instruments Incorporated Dynamic compensation of analog-to-digital converter (ADC) offset errors using filtered PWM
US20050214301A1 (en) * 2004-03-24 2005-09-29 Cell Signaling Technology, Inc. Antibodies specific for BCR-ABL fusion protein and uses thereof
US8124351B2 (en) * 2005-11-18 2012-02-28 Board Of Regents, The University Of Texas System Quantification of fusion proteins and their activity from chromosomal translocation
RU2558797C2 (ru) * 2009-10-20 2015-08-10 Нестек С.А. Способы выявления онкогенных слитых белков, основанные на анализе близкого взаимного расположения
US20120065092A1 (en) 2010-09-14 2012-03-15 Wai Hobert Fusion analyte cytometric bead assay, and systems and kits for performing the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083709A (en) * 1985-08-21 2000-07-04 Osi Pharmaceuticals, Inc. Immunoassay for detection of mutant P53 polypeptide in serum
US5447837A (en) * 1987-08-05 1995-09-05 Calypte, Inc. Multi-immunoassay diagnostic system for antigens or antibodies or both
WO1991007489A1 (en) * 1989-11-22 1991-05-30 Childrens Hospital Of Los Angeles Bcr/abl transgenic animals as models for philadelphia chromosome positive chronic myelogenous and acute lymphoblastic leukemia
ES2264239T3 (es) * 1990-06-27 2006-12-16 Princeton University Complejo de proteinas p53/p90'.
WO1992021032A1 (en) * 1991-05-24 1992-11-26 The Regents Of The University Of California Methods for the detection of bcr-abl and abnormal abl proteins in leukemia patients
ATE273386T1 (de) * 1991-09-20 2004-08-15 Hutchinson Fred Cancer Res Menschliches cyclin e
FR2691475B1 (fr) * 1992-05-20 1995-03-24 Centre Nat Rech Scient Séquence d'ADN des produits de fusion résultant de la translocation chromosomique récurrente t(11;22) (q24;q12) associée au développement d'un groupe de tumeurs cancéreuses.
US5667981A (en) * 1994-05-13 1997-09-16 Childrens Hospital Of Los Angeles Diagnostics and treatments for cancers expressing tyrosine phosphorylated CRKL protein
DE4444969C1 (de) * 1994-12-16 1996-10-24 Orga Med Dr Med Erwin Klopfer Nachweis von Antikörpern gegen p53 in Körperflüssigkeiten
US6150110A (en) * 1998-02-28 2000-11-21 The Brigham And Women's Hospital, Inc. HMGI(Y)-LAMA4* fusion oncogene, oncoprotein and methods of use

Also Published As

Publication number Publication date
CA2290656A1 (en) 1998-11-26
EP0983510B1 (de) 2004-03-03
PT983510E (pt) 2004-06-30
DE69822149T2 (de) 2005-03-03
AU7677198A (en) 1998-12-11
WO1998053317A1 (en) 1998-11-26
DE69822149D1 (de) 2004-04-08
CA2290656C (en) 2008-01-15
US6610498B1 (en) 2003-08-26
EP0983510A1 (de) 2000-03-08
ATE261125T1 (de) 2004-03-15
ES2217558T3 (es) 2004-11-01

Similar Documents

Publication Publication Date Title
EP1217377A3 (de) Verfahren zur spezifischen Detektion von Tumorzellen und ihren Vorstufen in Gebärmutterhalsabstrichen durch simultane Messung von mindestens 2 verschiedenen molekularen Markern
IL138497A0 (en) Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
BR0112385A (pt) Meio de coleta universal
EP1035215A3 (de) Verfahren und Sondenset zur Erkennung von Krebs
WO2001018252A3 (en) Methods for disease detection
BR9916840A (pt) Sistema de detecção biológica portátil integrado
ATE496288T1 (de) Gleichzeitige mehrfachanalyse klinischer proben
DE69823347D1 (de) Mikrofluidisches system und verfahren zu dessen betrieb
DE60142634D1 (de) Erkennung von tumor-spezifischen genprodukten bei krebs
WO2000052204A3 (en) Gene expression in bladder tumors
PT1137943E (pt) Metodo e reagentes para a deteccao de cancro
Große et al. Label-free imaging and spectroscopic analysis of intracellular bacterial infections
DK0983510T3 (da) Genkendelse af tumorspecifikke genprodukter i cancer
AU2740100A (en) A novel, prostate-specific gene for diagnosis, prognosis and management of prostate cancer
Oh et al. Rapid serial immunoprofiling of the tumor immune microenvironment by fine needle sampling
WO2002031209A3 (en) Genes related to development of refractory prostate cancer
ATE264922T1 (de) Verfahren zur erkennung von klonalen populationen von transformierten zellen in einer genomisch heterogenen zellulären probe
Corcoran Circulating tumor DNA: clinical monitoring and early detection
Földes-Papp ‘True’single-molecule molecule observations by fluorescence correlation spectroscopy and two-color fluorescence cross-correlation spectroscopy
DE69725297D1 (de) Immuno-magnetische zelltrennung zur erkennung von krebsmetastasenbildung-assozierten genen
Holman et al. Detecting exposure to environmental organic toxins in individual cells: toward development of a microfabricated device
Dogra et al. Sequencing and reproducibility analyses of small RNA extracted from prostate cancer exosomes isolated using nanoDLD chip technology
DK1042349T3 (da) Anvendelse af polyamid-nukleinsyre-oligomerer til frembringelse af et biologisk respons
Hsieh et al. Location and biomarker characterization of circulating tumor cells
Tiirikainen Detection of intracellular antigens by flow cytometry: Evaluation of a new permeabilization method for the detection of intracellular antigens in hematological malignancies.